{"id":"W2035105453","doi":"10.1007/s10637-009-9230-z","title":"A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503","year":2009,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":false,"ca_institutions":"Saint-Vincent Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Gemcitabine; Medicine; Internal medicine; Regimen; Lung cancer; Overall survival; Oncology; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001580816,0.0002564621,0.0005126999,0.00007273249,0.00009163842,0.000007443037,0.0001138816,0.0001142758,0.00002376788],"category_scores_gemma":[0.00008938875,0.0002276831,0.00008764357,0.0001294806,0.0001577332,0.000008495106,0.00005799194,0.0000650295,9.095806e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005129069,"about_ca_system_score_gemma":0.000775368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001159498,"about_ca_topic_score_gemma":0.0001793047,"domain_scores_codex":[0.9985618,0.0001116116,0.0005493723,0.000419346,0.0001681051,0.0001897849],"domain_scores_gemma":[0.9990419,0.00006764376,0.0003168256,0.0001992196,0.000215976,0.0001584828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01180595,0.006233251,0.0006034591,0.00004059555,0.0004193639,0.000009080252,0.008072913,0.000570282,0.9547031,0.00005547956,0.0004057814,0.01708075],"study_design_scores_gemma":[0.2064586,0.1125907,0.0004675574,0.00006837594,0.0002635503,0.000004926788,0.001429115,0.0004338932,0.6718812,0.000237414,0.005767701,0.0003969627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950911,0.002384547,0.00009989388,0.0004635659,0.0001424475,0.001357233,0.0001022256,0.000007830037,0.0003510946],"genre_scores_gemma":[0.9960207,0.000242168,0.001272641,0.0002390359,0.0004177955,0.0001054446,0.0001496842,0.00001640719,0.001536077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2828219,"threshold_uncertainty_score":0.9284648,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02281362557493624,"score_gpt":0.3220910436634508,"score_spread":0.2992774180885146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}